Article

Rheumatoid Arthritis Quiz: Adverse Pregnancy Outcomes

Author(s):

Ingrid Torjesen

Pregnancy and delivery are risky times for both mother and child for a number of reasons, but do you know by how much rheumatoid arthritis can increase those risks? Test your knowledge with this quiz.

Which the following adverse maternal outcomes does having rheumatoid arthritis during pregnancy most increase the odds of?


Related Videos
Marcelo Kugelmas, MD | Credit: South Denver Gastroenterology
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Related Content
US FDA logo in black over a white background. | Credit: US Food and Drug Administration
November 23rd 2024

FDA Approves Acoramidis (Attruby) for ATTR-CM

Patrick Campbell
Medical Ethics Unpacked: Ethical Considerations for Euthanasia and Medically-Assisted Suicide
November 22nd 2024

Medical Ethics Unpacked: Ethical Considerations for Euthanasia & Medical Assistance in Dying

Steven Levine, MD Dominic Sisti, PhD
Gildeuretinol for Stargardt Secures FDA Rare Pediatric, Fast Track Status | Image Credit: Vitreo Retinal Associates
November 22nd 2024

Gildeuretinol for Stargardt Secures FDA Rare Pediatric, Fast Track Status

Connor Iapoce
Medical Ethics Unpacked:
November 22nd 2024

Medical Ethics Unpacked: Ethical Foundations and Background of Euthanasia & Medically-Assisted Suicide

Steven Levine, MD Dominic Sisti, PhD
Study Identifies Homelessness as a Predictor Against Clozapine Use
November 22nd 2024

Study Identifies Homelessness as a Predictor Against Clozapine Use

Chelsie Derman
FDA Issues CRL to Avacincaptad Pegol sNDA for Geographic Atrophy | Image Credit: US Food and Drug Administration
November 22nd 2024

FDA Issues CRL to Avacincaptad Pegol sNDA for Geographic Atrophy

Connor Iapoce
© 2024 MJH Life Sciences

All rights reserved.